Allarity Therapeutics Inc (ALLR): This allr gonna get delisted or make an...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	15
Posts	2149
Boards Moderated	0
Alias Born	04/05/2017

Pt3

Re: None

Tuesday, 04/18/2023 1:17:15 PM

Tuesday, April 18, 2023 1:17:15 PM

This allr gonna get delisted or make an appeal tooo risky

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ALLR News

Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2024 12:00:29 PM
Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement • GlobeNewswire Inc. • 10/10/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 12:00:34 PM
Allarity Therapeutics Strengthens Leadership with Key Appointments to Accelerate Stenoparib PARP Inhibitor Program • GlobeNewswire Inc. • 10/03/2024 12:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 09:34:12 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 09:32:57 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 12:00:32 PM
Allarity Therapeutics Announces Two Patients Now Exceeding One Year of Treatment with Stenoparib in Advanced Ovarian Cancer Trial • GlobeNewswire Inc. • 09/16/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2024 12:53:18 PM
Allarity Therapeutics Announces New CFO and Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/13/2024 12:45:00 PM
Allarity Therapeutics Takes Decisive Step Toward Regaining Nasdaq Compliance with Nasdaq Listing Rule 5550(a)(2) • GlobeNewswire Inc. • 09/11/2024 12:00:00 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/10/2024 01:15:59 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/09/2024 08:05:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 01:00:09 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/30/2024 08:05:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 08:55:50 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/05/2024 09:24:15 PM
Allarity Therapeutics Announces Postponement of Annual Stockholders Meeting • GlobeNewswire Inc. • 07/26/2024 01:00:00 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/26/2024 10:04:13 AM
Allarity Encourages Shareholders to Vote FOR the Reverse Stock Split and Decrease in Authorized Shares • GlobeNewswire Inc. • 07/24/2024 10:00:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 08:05:17 PM
Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives • GlobeNewswire Inc. • 07/22/2024 10:30:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/22/2024 10:03:17 AM

More ALLR News

InvestorsHub NewsWire

Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM

SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM

Future Hospitality Ventures Unveils Bold, New AI-Driven Initiative to Revolutionize the $300 Billion Hospitality Market • NGTF • Oct 16, 2024 7:07 AM

Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM

One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM

ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • BURU • Oct 15, 2024 8:21 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover